Medical Devices

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Insights, Forecast to 2025

  • QYR2789054
  • 114 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
The global Benign Prostatic Hyperplasia (BPH) Treatment Devices market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Benign Prostatic Hyperplasia (BPH) Treatment Devices market based on company, product type, end user and key regions.

This report studies the global market size of Benign Prostatic Hyperplasia (BPH) Treatment Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Benign Prostatic Hyperplasia (BPH) Treatment Devices in these regions.

This research report categorizes the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market by top players/brands, region, type and end user. This report also studies the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Endo International (US)

Karl Storz (Germany)

Medtronic (US)

Siemens (Germany)

Lumenis (Israel)

Olympus (Japan)

Urologix (US)

NeoTract (US)

Boston Scientific (US)

Urotech (Germany)

Toshiba (Japan)

Baxter International (US)

Market size by Product

Laser Based Procedure

Other Energy Based Procedure

Market size by End User

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Other

Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.

To understand the structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Benign Prostatic Hyperplasia (BPH) Treatment Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Benign Prostatic Hyperplasia (BPH) Treatment Devices submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Benign Prostatic Hyperplasia (BPH) Treatment Devices are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Benign Prostatic Hyperplasia (BPH) Treatment Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by Product

1.4.2 Laser Based Procedure

1.4.3 Other Energy Based Procedure

1.5 Market by End User

1.5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by End User

1.5.2 Hospitals

1.5.3 Ambulatory Surgical Centers

1.5.4 Specialty Clinics

1.5.5 Other

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size

2.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2013-2025

2.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2013-2025

2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Growth Rate by Regions

2.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Regions

2.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturers

3.1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturers

3.1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Manufacturers

3.1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Concentration Ratio (CR5 and HHI)

3.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Manufacturers

3.2.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Manufacturers (2013-2018)

3.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2013-2018)

3.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Manufacturers

3.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base Distribution, Product Types

3.4.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type

3.4.3 Date of International Manufacturers Enter into Benign Prostatic Hyperplasia (BPH) Treatment Devices Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product

4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Product

4.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Breakdown Data by End User

6 North America

6.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries

6.1.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries

6.1.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product

6.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User

7 Europe

7.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries

7.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries

7.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product

7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User

8 Asia Pacific

8.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries

8.1.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries

8.1.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product

8.3 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User

9 Central & South America

9.1 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries

9.1.1 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries

9.1.2 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product

9.3 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User

10 Middle East and Africa

10.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices by Countries

10.1.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries

10.1.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product

10.3 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices by End User

11 Company Profiles

11.1 Endo International (US)

11.1.1 Endo International (US) Company Details

11.1.2 Company Business Overview

11.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.1.4 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.1.5 Endo International (US) Recent Development

11.2 Karl Storz (Germany)

11.2.1 Karl Storz (Germany) Company Details

11.2.2 Company Business Overview

11.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.2.4 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.2.5 Karl Storz (Germany) Recent Development

11.3 Medtronic (US)

11.3.1 Medtronic (US) Company Details

11.3.2 Company Business Overview

11.3.Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.3.4 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.3.5 Medtronic (US) Recent Development

11.4 Siemens (Germany)

11.4.1 Siemens (Germany) Company Details

11.4.2 Company Business Overview

11.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.4.4 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.4.5 Siemens (Germany) Recent Development

11.5 Lumenis (Israel)

11.5.1 Lumenis (Israel) Company Details

11.5.2 Company Business Overview

11.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.5.4 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.5.5 Lumenis (Israel) Recent Development

11.6 Olympus (Japan)

11.6.1 Olympus (Japan) Company Details

11.6.2 Company Business Overview

11.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.6.4 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.6.5 Olympus (Japan) Recent Development

11.7 Urologix (US)

11.7.1 Urologix (US) Company Details

11.7.2 Company Business Overview

11.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.7.4 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.7.5 Urologix (US) Recent Development

11.8 NeoTract (US)

11.8.1 NeoTract (US) Company Details

11.8.2 Company Business Overview

11.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.8.4 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.8.5 NeoTract (US) Recent Development

11.9 Boston Scientific (US)

11.9.1 Boston Scientific (US) Company Details

11.9.2 Company Business Overview

11.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.9.4 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.9.5 Boston Scientific (US) Recent Development

11.10 Urotech (Germany)

11.10.1 Urotech (Germany) Company Details

11.10.2 Company Business Overview

11.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2013-2018)

11.10.4 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered

11.10.5 Urotech (Germany) Recent Development

11.11 Toshiba (Japan)

11.12 Baxter International (US)

12 Future Forecast

12.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Regions

12.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Regions 2018-2025

12.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Regions 2018-2025

12.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Product

12.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Product 2018-2025

12.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Product 2018-2025

12.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by End User

12.4 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast

12.5 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast

12.6 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast

12.7 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast

12.8 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables and Figures

Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Picture

Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segments

Table Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Covered

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product 2013-2025

Figure Laser Based Procedure Product Picture

Table Major Manufacturers of Laser Based Procedure

Figure Other Energy Based Procedure Product Picture

Table Major Manufacturers of Other Energy Based Procedure

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by End User 2018-2025 (K Units)

Figure Hospitals

Figure Ambulatory Surgical Centers

Figure Specialty Clinics

Figure Other

Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Report Years Considered

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size 2013-2025 (Million US$)

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2013-2025 (K Units)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Regions 2013-2018 (K Units) & (Million US$)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Regions 2013-2018 (K Units)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions 2013-2018

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions 2013-2018

Figure 2017 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Regions 2013-2018 (Million US$)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions 2013-2018

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions 2013-2018

Figure 2017 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturers (2013-2018) (K Units)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Manufacturers (2013-2018)

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Manufacturers in 2017

Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Manufacturers (2013-2018) (Million USD)

Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2013-2018)

Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Value Share by Manufacturers in 2017

Table Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (2013-2018) (USD/Unit)

Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type

Table Date of International Manufacturers Enter into Benign Prostatic Hyperplasia (BPH) Treatment Devices Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Product (2013-2018)

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product in 2017

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Product (2013-2018) (Million US$)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Product (2013-2018)

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Product (2013-2018)

Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Product in 2017

Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Product 2013-2018 (USD/Unit)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by End User (2013-2018)

Figure Global Sales Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User (2013-2018)

Figure Global Sales Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User in 2017

Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)

Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)

Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)

Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)

Figure 2017 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries

Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)

Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)

Figure 2017 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries

Figure United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (K Units)

Figure Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)

Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)

Figure 2017 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product

Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)

Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)

Figure 2017 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User

Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)

Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)

Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)

Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)

Figure 2017 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries

Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)

Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)

Figure 2017 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries

Figure Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure France Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure France Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)

Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)

Figure 2017 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product

Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)

Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)

Figure 2017 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User

Figure Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)

Figure Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)

Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)

Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)

Figure 2017 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries

Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)

Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)

Figure 2017 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries

Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Malaysia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Malaysia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Philippines Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Philippines Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Thailand Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Thailand Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Vietnam Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Vietnam Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Singapore Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Singapore Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)

Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)

Figure 2017 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product

Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)

Table Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)

Figure 2017 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User

Figure Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)

Figure Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)

Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)

Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)

Figure 2017 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries

Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)

Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)

Figure 2017 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries

Figure Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)

Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)

Figure 2017 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product

Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)

Table Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)

Figure 2017 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User

Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2013-2018 (K Units)

Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2013-2018 (Million US$)

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Countries (2013-2018) (K Units)

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries (2013-2018)

Figure 2017 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Countries

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries (2013-2018) (Million US$)

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries (2013-2018)

Figure 2017 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Countries

Figure GCC Countries Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure GCC Countries Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Figure South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate (2013-2018) (K Units)

Figure South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2013-2018) (Million US$)

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Product (2013-2018) (K Units)

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Product (2013-2018)

Figure 2017 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Product

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by End User (2013-2018) (K Units)

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by End User (2013-2018)

Figure 2017 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by End User

Table Endo International (US) Company Details

Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Endo International (US) Recent Development

Table Karl Storz (Germany) Company Details

Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Karl Storz (Germany) Recent Development

Table Medtronic (US) Company Details

Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Medtronic (US) Recent Development

Table Siemens (Germany) Company Details

Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Siemens (Germany) Recent Development

Table Lumenis (Israel) Company Details

Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Lumenis (Israel) Recent Development

Table Olympus (Japan) Company Details

Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Olympus (Japan) Recent Development

Table Urologix (US) Company Details

Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Urologix (US) Recent Development

Table NeoTract (US) Company Details

Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table NeoTract (US) Recent Development

Table Boston Scientific (US) Company Details

Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Boston Scientific (US) Recent Development

Table Urotech (Germany) Company Details

Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Urotech (Germany) Recent Development

Table Toshiba (Japan) Company Details

Table Baxter International (US) Company Details

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Regions 2018-2025 (K Units)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Regions 2018-2025

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Regions 2018-2025 (Million US$)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Regions 2018-2025

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Product 2018-2025 (K Units)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Product 2018-2025

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Product 2018-2025 (Million US$)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Product 2018-2025

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by End User 2018-2025 (K Units)

Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by End User 2018-2025

Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)

Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Forecast of Global Middle-Class Population, 2015 to 2030

Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016

Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Value Chain

Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers List

Table Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370